 Connection
Marc Bonaca to Peptide Fragments
This is a "connection" page, showing publications Marc Bonaca has written about Peptide Fragments.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.404 |
|
|
|
-
Bonaca MP, Wiviott SD, Sabatine MS, Buros J, Murphy SA, Scirica BM, Rifai N, Antman EM, Morrow DA. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Am J Cardiol. 2007 Feb 01; 99(3):344-8.
Score: 0.188
-
Martins EB, Madrini V, Ramos Souza PV, Tavares CAM, Albuquerque MT, Santo KE, Harrington JA, Canonico ME, El Rafei A, Bonaca MP, Guimaraes PO. ANSWER-HF: sacubitril-valsartan reduces NT-proBNP in heart failure due to Chagas cardiomyopathy despite no reverse remodeling. Heart Fail Rev. 2026 03 23; 31(1).
Score: 0.179
-
Marston NA, Garfinkel AC, Kamanu FK, Melloni GM, Roselli C, Jarolim P, Berg DD, Bhatt DL, Bonaca MP, Cannon CP, Giugliano RP, O'Donoghue ML, Raz I, Scirica BM, Braunwald E, Morrow DA, Ellinor PT, Lubitz SA, Sabatine MS, Ruff CT. A polygenic risk score predicts atrial fibrillation in cardiovascular disease. Eur Heart J. 2023 01 14; 44(3):221-231.
Score: 0.036
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|